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Introduction
Nodular thyroid disease is commonly found in adult pop-
ulations, especially in females and the elderly. It can be de-
tected in 3%-7% by palpation and 20%-76% by ultrasonic 
devices,1-3 and has had an estimated growth of 5% in each 
year.4 Thyroid nodules are different in their shape, size, 
content, echogenicity, echotexture, presence of calcifica-
tions, margins, vascularity, and elastosonography. They 
may also be several in number in a thyroid goiter. Endo-
crinologists may classify them as malignant, suspicious 
for malignancy, borderline, probably benign, and benign,2 
with a malignancy rate of 5%-15% which depends on age, 
gender, radiation exposure and family backgrounds.4,5 No 
special treatment do most of benign thyroid nodules re-
quire, however, pressure symptoms or cosmetic reasons 
may call for a therapy.1,3,6,7
Method
This paper reviews the major treatment methods that have 
been administered for this disease, with a special concern 
to the laser thermal ablation method, describing its histo-
ry, process, efficacy, cost analysis and a comparison to the 
other methods. To provide this, several published papers 
in the area of treatment of benign thyroid nodules were 
reviewed, then the reference list from selected papers were 
examined to find older relevant reports, and once again, 
those papers that have cited the selected pioneer studies 
were examined to collect the most recent information 
about thermal ablation methods. A total amount of about 
130 papers were examined, with a full-text review of 25 
reports on thermal ablation therapies of benign thyroid 
nodules, with emphasis on both the completeness and 
novelty of the selected papers.
Treatment Methods
Several treatment methods have been suggested and per-
formed to date: Surgery, suppression of thyroid-stimulat-
ing hormone (TSH) with levothyroxine, and radioactive 
iodine as the traditional technics, and ethanol ablation, 
radiofrequency ablation (RFA), laser ablation and micro-
wave ablation (MWA) as the new percutaneous ablation 
therapies, a glance of which is provided in this section.
1. Surgery
As the standard therapy, surgery has been known to be 
the most effective, and consequently, the most common 
treatment for thyroid nodules. It is reasonably safe, and 
can be done in many surgical centers, although a thyroid 
unit and a specialist may be needed in the case of com-
plications. Compared to the other treatment methods of 
thyroid nodule, surgery has been always higher in the risk 
of complications, that is, complications are seen in 2% to 
10% of patients, and it is considerably more expensive.8,9
Long hospitalization, scar formation, iatrogenic hypothy-
roidism, and difficulty in reoperation can be mentioned 
as the most common drawbacks of surgery,3 and patients 
with previous lobectomies, or those who are to undergo 
reoperations, are so exposed to morbidity or complica-
tions that their eligibility for surgery can be extremely 
limited.8,10
2. Thyroid-Stimulating Hormone Suppression
A sufficient dose of exogenous thyroid hormone is ad-
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ministered to cause the thyroid gland to stop growing, and 
hence, so does the nodule. There is no agreement on the 
efficacy and safety of this method, and the outcome has 
been questioned when the nodule is larger.7
3. Radioactive Lodine
The use of radioiodine for benign nodules has had a con-
tinuous discussion on its potential to make the nodule 
malignant. Thyroid absorbs almost all iodine the body 
takes, and does so with radioactive iodine, 131I, if taken by 
the patient, so the tissue will be destroyed.
4. Percutaneous Ethanol Ablation
High concentrated ethanol can be used to destroy the un-
desired tissue. Before the injection of ethanol, the whole 
fluid or colloid inside the cyst has to be aspirated using 
a syringe with the help of normal saline. The amount of 
ethanol will be a little more than half of aspirated fluid and 
the retention time is about 2 minutes.5
The use of percutaneous ethanol therapy in thyroid dis-
eases, especially in solid nodules, has been limited due to 
the seepage of ethanol into perinodular tissue, which is 
the cause of pain and other complications, but remains as 
an effective method of treating cystic ones.11 In addition to 
the adverse effects of ethanol seepage, the fact of not being 
able to ablate the undesired tissue in a regular, homoge-
neous, and reproducible way has been mentioned as the 
limitation of percutaneous ethanol ablation.12
5. Radiofrequency Ablation 
A new, reportedly safe, minimally invasive and low cost 
approach to the treatment of benign thyroid nodules that 
has been introduced in 2006 is to agitate ions in nodule 
tissue by the oscillations of high-frequency alternating 
electric current from a thin electrode needle inserted into 
the center of the nodule. As the ions follow the oscilla-
tions, frictional heating ablates nearby tissue.13
Reasonable amount of clinical research with follow up pe-
riods has proven the efficacy and safety of this method. 
One point of discussion is the significant thermal pattern 
that exist around the needle, as the tissue regions very 
close to it get far more heated than remote tissue which is 
only heated via thermal conduction of heat generated in 
closer regions,13,14 and certain cases have been reported to 
experience controllable complications such as pain, voice 
change, thermal nerve injury, perithyroidal hematomas, 
skin burn or color change, and nodule rupture.15,16
6. Microwave Ablation 
Another new minimally invasive approach to the treat-
ment of benign thyroid nodules is microwave ablation. A 
3 mm microwave antenna is inserted into the center of the 
nodule through a 2 mm incision to ablate it by microwave 
radiation. This approach of treatment seems to be safe, 
relatively low in cost, and short in period, yet, there are 
issues remaining to be resolved, e.g. a fixed-antenna ab-
lation will result in a cylindrical ablated zone despite the 
fact that most nodules are rather elliptical, and prolonged 
fixation of the antenna can harm surrounding structures. 
Further studies have to shed light on the efficacy and safe-
ty of this method.3
7. Laser Ablation
Of special concern to this paper is the application of ther-
mal effects of laser in ablating thyroid nodules. Among the 
new minimally invasive methods proposed in recent years, 
laser ablation is shown to possess several advantages, in 
particular, the ability of defining a regular, homogeneous, 
and reproducible pattern of ablation. The procedure of la-
ser ablation therapy accompanied by a description of the 
state of the art in clinical results, efficacy, complications 
and expenses of this method is provided in this paper.
8. Mixed Methods
In order to be more effective, RFAs can be usually pre-
ceded by a preparatory aspiration of internal fluid if the 
nodule is predominantly cystic, which may cause internal 
bleeding. Yoon et al17 proposed and evaluated a primary 
ethanol ablation to control this problem before starting 
RFA, and obtained successful feasibility and safety results, 
with less complications and shorter treatment time.
Laser Ablation of Thyroid Nodules
History
The feasibility of the use of laser to ablate benign thyroid 
nodules was first published in 2000 after it was tested in 
the late 1990s on 18 resected thyroid glands, with no dif-
ficulties, and thereafter, on two volunteers again with no 
much complication but a mild pain ceasing just after the 
power was turned off.12 The authors suggested to limit the 
use of this method to only benign cases, which reducing 
the size of nodule itself alleviates the problem.
Two years later, Døssing et al18 published a satisfactory re-
sult of laser ablation that they had achieved by illuminat-
ing laser to benign thyroid nodules of 16 patients, against 
a control group of the same size. According to their report, 
one session of laser therapy with one illuminating fiber 
resulted in a reduction of about 46% before 6 months.
Later, Spiezia et al19 published further results confirming 
the efficacy of this method on 7 patients with autonomous 
hyperfunctioning thyroid nodules and five patients with 
compressive nodular goiters. Also, Papini et al20 complet-
ed their first introduced method by providing clinical re-
sults of volume and symptom reduction of thyroid benign 
nodules.
After several successful clinical results were published, 
the American Association of Clinical Endocrinologists/
Associazione Medici Endocrinologi (Italian Association 
of Clinical Endocrinologists)/European Thyroid Associa-
tion (AACE-AME-ETA) recommended in 2010 that laser 
ablation therapy can be a safe and effective option for the 
treatment of benign thyroid nodules.6
Target Patients
Laser ablation is a considerable option for the treatment 
of benign thyroid nodules (cold nodules, cystic nodules, 
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and autonomously functioning thyroid nodules) in the 
patients who have:
• significant nodule-related symptoms,
• local pressure symptoms,
• cosmetic complaints,
• obvious outer convex,
• foreign body sensation,
• neck discomfort,
• pain,
• or a recent noticeable increase in the nodule size,
• as well as those who either refuse operation or are not 
eligible for surgery, or patients that psychologically 
suffer from frequent clinical examinations.3,6
Preparation
Laser ablation therapy is an outpatient percutaneous pro-
cedure. Subjects need to be fasting, with careful local an-
esthesia, but they can be conscious (with a light sedation 
administered) and there is no need for the presence of an 
anesthesiologist, though it is recommended to perform 
the therapy in a center with an available anesthesiologist 
and a surgeon as well as an endocrinology unit, and to 
have emergency care including a defibrillator prepared in 
the interventional suite.6,9
Equipment
Almost all laser equipment reported to be used in this 
method are diode lasers (A = 800-980 nm) or lasers with 
a medium of the crystals of Nd:YAG (neodymium-doped 
yttrium aluminum garnet or Nd:Y3Al5O12) operating 
at 1064 nm and operation power of about 2-4 W. A 300 
to 400 pm-diameter plane-cut optic fiber is inserted into 
the center of the thyroid nodule through the sheath of a 
21-gauge Chiba needle, and is locked to be in direct con-
tact with the tissue, not more than the appropriate length, 
i.e. about 5 to 20 mm. A single fiber will produce a 2 cm 
nearly spherical shape of coagulative necrosis, therefore, 
due to the ellipsoid shape and larger size of the nodules 
being treated, multiple ablation sessions or multiple fiber 
insertions arrayed 10 to 18 mm from each other are often 
needed.
Most thyroid nodule ablations are guided with real-time 
ultrasonic images on an auxiliary monitor placed on a 
tower at the end of the operation table.6,9
Procedure
The procedure mainly requires an operator behind the 
operation table, and an assistant on the right of it operat-
ing the ultrasonic imaging device. The patient will be po-
sitioned in supine with hyperextended neck. After admin-
istering local anesthesia, based on the size and the shape 
of the nodule, and the strategy of ablation as if the ablation 
will be performed in one or more sessions, one to four nee-
dles will be inserted along the longitudinal, cranio caudal, 
and major nodule axes. Fibers may be reinserted in 10 mm 
increments to exert the power in further regions, while 
observing a clearance of 5 mm from the cranial portion of 
the nodule. The total energy applied, operation time and 
number of fibers or sessions are determined according to 
the shape and size of the nodule. Nodules smaller than 5 
mm in diameter may need only one optic fiber for one 
session of 6 minutes, and larger ones with the maximum 
width, thickness and length of 50, 35, and 70 mm (i.e. with 
the maximum volume of 60 mL) require a combination of 
multiple fibers placed or pull-backed, higher energy, and a 
duration extended to 30 minutes.6
Follow Up
When the laser ablation proceeds to its end, patients will 
be administered with a 20 mg bolus of prednisone to con-
trol possible rheumatic and allergic conditions, and an ice 
pack is pushed slightly on their neck. Then they have to be 
under observation for about 2 hours in a recovery room, 
and undergo ultrasonic examination to check if they are 
clear to leave. On the next 3 days, an oral prednisone ther-
apy consisting of 25 mg/day is administered followed by 
12.5 mg/day for another three days and 5 mg/day for 4 
days. Besides 30 mg lansoprazole is administered for 10 
days.6 Follow up examinations are recommended to be 
done after 1, 2, and 6 months, followed by every 6 or 12 
month interval examinations depending on the situation 
of the case.5
Efficacy: Selected Clinical Results
It is probably no exaggeration to state that thermal abla-
tion therapies for benign thyroid nodules are still at their 
infancy. Nearly all the research in this area has taken place 
in Italy and Korea.7
This section highlights eight published clinical results 
that examined the efficacy of laser ablation on patients 
with different nodule type, size, and background, in dif-
ferent centers, with different methods, and with different 
equipment. 
Gambelunghe et al21 designed a randomized controlled 
study on 26 patients who had either a high risk of surgery 
or compressive symptoms due to benign thyroid nodules. 
After 2 weeks, the intervention group demonstrated a re-
duction of 22% in the volume of their nodule, which yield-
ed to 44% after 30 weeks. They also found evidence of a 
positive correlation between the amount of energy exerted 
and the reduction volume.
Døssing et al22 compared the efficacy of one interstitial la-
ser photocoagulation session with one radioiodine (131I) 
dose on two randomized groups of 15 patients with sub-
clinical or mild hyperthyroidism. Comparing the results 
at baseline, 1, 3 and 6 months, they observed the normal-
ization of serum TSH in 7 out of 14 patients in the intersti-
tial laser photocoagulation group and in all 15 patients in 
the radioiodine group. They also found a nodule volume 
reduction of about 44% in the first and about 47% in the 
latter group.22
In a comparative study on 62 randomly grouped pa-
tients with solid benign nodules, Papini et al23 examined 
the results of a 10 minutes of 1.064 pm 3 W radiation of 
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neodymium yttrium-aluminum-garnet laser, and also 
the effect of a dose of levothyroxine suppressive therapy 
against a non-treated control group. They found signifi-
cant reduction (about 42.7%) of nodule volume in group 
1, no significant shrinkage in group 2, and non-significant 
increase in the control group.23
Valcavi et al24 for the first time conducted a 3-year follow 
up to examine the results of laser ablation over a group of 
122 patients with benign cold thyroid solitary nodules or a 
dominant nodule within a normo-functioning multinod-
ular goiter. Three years after PLA, they observed a nod-
ule volume decrease of about 47.8% (with a deviation of 
33.1%), improved symptoms in 73.0%, and improved cos-
metic signs in 71.3%. They reported also few cases of la-
ryngeal dysfunction, voice changes and hypothyroidism.24
Amabile et al25 tested the effect of one to three cycles of 
laser ablation with an interval of 1 month on 51 patients 
with non-functioning thyroid nodules and 26 patients 
with hyperfunctioning thyroid nodules. They observed 
that a significant nodule volume reduction occurred in 
both groups, 87% of whom were cured with no major 
complications, but reported some mild pain, vasovagal 
reaction, and fever. 
Døssing et al26 published a 10 year result of their follow 
up after laser ablation therapy on 78 patients with solitary 
benign thyroid nodules, which shows a reduction with a 
median of 51% in nodule volume. Twenty-one patients 
retired from the follow up earlier due to surgery, but side 
effects were limited to mild local pain. 
Døssing et al27 examined the effect of laser ablation on im-
proving the results of cystic benign nodule aspiration on 
44 randomly grouped patients. Six months after the aspi-
ration session, they achieved a cyst volume less than 1 mL 
in 68% of patients that underwent an additional session of 
laser ablation, and only 18% of the control group with no 
laser therapy. Also, the size of the solid part of the nodules 
reduced from 1.8 to 1.0 mL by the laser ablation, while it 
had no significant change in the control group. 
Achille et al28 evaluated laser ablation therapy on 45 pa-
tients complaining of either pressure or cosmetic distress 
due to benign solid (max fluid 20%) thyroid nodules, 
between October 2009 and January 2011. They used 
Nd:YAG laser at 1064 nm 3 W power with varying dura-
tions. Evaluations were done at baseline, 6 and 12 months. 
Their outcomes showed a reduction of about 20 mL at 12 
months (84% ± 13%), with resolved cosmetic signs in 87% 
and resolved pressure symptoms in 88%. They also report-
ed one case of rare complication, i.e. voice change. 
Side Effects
The reported complications of laser ablation have not 
been serious. Cakir et al29 observed slight intra-opera-
tion ear-pain on the side of the ablation and subsequent 
pain in swallowing for a few days in 4 of their 12 patients 
that ceased with paracetamol. Studies with larger samples 
and follow-ups have shown some controlled intranodu-
lar bleeding during needle placement that did not termi-
nate the procedure. Thyroid pericapsular bleeding, vagal 
symptoms with bradycardia, voice change, and cough 
each appeared in about 2% of patients. Three percent of 
them experienced fluid leakage into the neck muscle fas-
cia, and 5% pseudocyst transformation. Six months after 
the ablation, the rate of thyroid dysfunction among the 
patients were about 3% with no clue if it has been due to 
laser ablation.6 Other adverse effects such as dysphony, 
hematoma burns and transient stridor have been quite 
rare.9 In a recent report, Achille et al28 observed that only 
one patient out of 40 patients experienced dysphonia, who 
found his normal voice after 8 weeks of care, one other pa-
tient experienced intense local pain, another experienced 
hyperpyrexia, but mild to moderate local pain occurred 
in 12 of them.
Cost Analysis
There are quite few published financial analyses of the ex-
penses of laser ablation, but it is mentioned to be less ex-
pensive than other methods. Gharib et al9 provided some 
price list data about the equipment used in this method 
with some variations in attributes, but no analysis of the 
total price each operation may save or impose has been 
provided. Longo et al4 tried to figure out the financial 
effect of provisioning laser ablation operations on the fi-
nancial balance of a hospital. Although they found that 
every operation can be considered as a financial loss to the 
hospital, they assessed continuing to perform this method 
as a reputation to it, which is difficult to describe in eco-
nomic scales. Besides, they suggested they had not enough 
information as if the hospital would have provisioned the 
other alternative methods. 
Comparison
Ethanol ablation therapy has been known as the first-line 
treatment for benign thyroid nodules, especially in cystic 
ones.30 As the solid component of a nodule increases, how-
ever, ethanol ablation will be less effective even with re-
peated treatments. Thermal ablation methods have shown 
better outcomes when the nodule was not totally cystic, 
but predominantly cystic. Ethanol has not been reported 
to be successful in ablation of the solid component, which 
has been known to cause the recurrences observed a few 
months later. When a nodule is categorized as predomi-
nantly solid, ethanol ablation has not been considered as 
an appropriate method,5 and it has been completely aban-
doned for the solid ones.28
Among thermal ablation therapies for thyroid benign ab-
lation, RFA has shown a little superiority in results to la-
ser ablation method.15,31 Ha et al1 reviewed 33 published 
clinical results that have evaluated either radiofrequency 
or laser ablation methods. They concluded that a single 
electrode radiofrequency treatment would result in better 
(76.1%) reduction volumes than a single fiber laser treat-
ment (49.9%). They suggested this superiority could be a 
result of the moving-electrode technic in radiofrequency, 
while managing multiple fibers in thyroid could be more 
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difficult. Besides, they suggested that radiofrequency ap-
proach has been better in the ablation of marginal compo-
nents which may have prevented marginal regrowth. They 
concluded that more randomized clinical research would 
be required to decide about the actual efficacy, cost, safety, 
and long term efficacy of both methods. 
Conclusion
Non-surgical approaches to the treatment of benign thy-
roid nodules have been largely considered in recent years. 
Laser ablation is one of the newest thermal ablation meth-
ods that has shown a reasonable efficacy with quite little 
complications, although there are important questions on 
how to improve the outcomes by producing a heating re-
gion similar to the shape of undesired tissue. It is not yet 
the time to decide definitively about the possible superior-
ities among the three thermal ablation approaches, since 
a required amount of outcomes, especially long-term fol-
low-up results, has not been accumulated. Different types 
of benign thyroid nodules have to be treated by controlled 
and randomized examinations, well established selection 
criteria have to illuminate the best treatment method for 
each patient, and technological improvements must facil-
itate nodule ablations with desired shapes. Laser ablation 
is such an inexpensive, effective, safe, and minimally in-
vasive method that can be an appropriate alternative for 
debulking benign thyroid nodules.
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